INTERNATIONAL DOWN SYNDROME MEDICAL INTEREST GROUP MEETING
At the 11th World Down Syndrome Congress, Cape Town, South Africa
Venue: Cape Town International Convention Centre
14 August, 2012 - 1pm to 6pm
Provisional Programme
Chair: Dr Liz Marder, Consultant Paediatrician, Nottingham University Hospitals, UK and Meetings
Convenor, DSMIG (UK and Ireland)
12.00
Registration for those registered on DSMIG meeting and main congress
13.00
Opening address: My appeal to health providers
Ms Jaspreet Kaur Sekhon, Self-advocate, Singapore
13.20
Delegate introductions
Each delegate to introduce themselves, their interest in Down Syndrome and a brief over view of
services in their country
14.30
Service co-ordination for children with Down Syndrome in Cape Town: The Red Cross
experience
Dr Shetil Nana, Paediatric Registrar & Dr Kirsty Donald, Senior Specialist, Division of Developmental
Paediatrics Red Cross Children's Hospital and UCT, South Africa
15.00
DSMIG UK and Ireland – recent activity, new developments to include new PCHR insert and
growth charts
Dr Marian McGowan, Consultant Paediatrician, St George’s Hospital London and Chairman, DSMIG
UK and Ireland
15.15
USA Revision Of Health Care Guidelines For Persons With Down Syndrome
Siegfried M.Pueschel MD, PhD, JD, MPH, Professor of Pediatrics Brown University, Providence, RI,
USA
15.30
Developing DSMIG International
Dr Balbir Singh, Vice Chair, Board of Trustees, Down Syndrome International; Advisor & Founding
Chair DSA Singapore & Dr Bhavani Sriram, Medical Advisor, Down Syndrome Association, Singapore
Senior Consultant Neonatologist, KK Women's & Children Hospital, Singapore
15.45
Refreshments
16.00
Hot Topic – Cancer in people with Down Syndrome
Daniel Satgé MD, PhD, ONCODEFI Project, Epidemiology and Biostatistics, Institut Universitraire de
Recherche Clinique, Montpellier, France
16.45
Short Papers:
Epidemiological study on skin and hair in a cohort of 90 French persons with Down syndrome Jacqueline London, President of the French Association for Research on Trisomy 21 Professor in
Molecular Pathology, Life Sciences Department University Paris-Diderot
Corneal Collagen Crosslinking (CXL) and new therapeutic options to treat progressive
keratoconus - Farhad Hafezi MD PhD, Professor and Chair of Ophthalmology Department of Clinical
Neurosciences University Hospitals of Geneva, Switzerland
The positive impact of the Developmental Resource Stimulation Programme on the
developmental domains of the child with Down syndrome younger than 42 months Dorothy C Russell, Director: Bloemfontein Child Information Centre Occupational Therapist at
Department Paediatric and Child Health University of the Free State, South Africa
17.30
Interesting Cases
18.00
Close